Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm of the Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03394690
What this trial is testing

Effects of Green Coffee Extract Supplementation on Leptin, Ghrelin, Adiponectin,Anthropometric Measurements, Lipid Profile in Breast Cancer Survivors

Who this might be right for
Breast Cancer Survivors
National Nutrition and Food Technology Institute 50
Post-approval studies (Phase 4)UnknownNCT00129597
What this trial is testing

Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy

Who this might be right for
PainBreast Cancer
Hospices Civils de Lyon 40
Testing effectiveness (Phase 2)Study completedNCT00010010
What this trial is testing

Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
NYU Langone Health
Not applicableStudy completedNCT04503018
What this trial is testing

Psychological Effects of Implant Loss

Who this might be right for
Breast Cancer Female
Vastra Gotaland Region 150
Not applicableStudy completedNCT06669910
What this trial is testing

Investıgatıon of Temporomandıbular Dysfunctıon in Patıents Wıth Breast Cancer-Related Lymphedema

Who this might be right for
Breast CancerLymphedema
arife akbulut 38
Early research (Phase 1)Temporarily pausedNCT05076591
What this trial is testing

IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced Breast CancerAdvanced Gastric Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 135
Testing effectiveness (Phase 2)Study completedNCT03112590
What this trial is testing

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, MaleBreast Cancer Female+1 more
H. Lee Moffitt Cancer Center and Research Institute 51
Not applicableEnrolling By InvitationNCT06821490
What this trial is testing

Validation of TAD in HER-2 with More Than 2 Lymph Nodes

Who this might be right for
Breast Carcinoma Metastatic in Lymph NodeHER2 Positive Breast Carcinoma
Fundación para la Investigación del Hospital Clínico de Valencia 21
Large-scale testing (Phase 3)Active Not RecruitingNCT04443413
What this trial is testing

Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
Mayo Clinic 146
Testing effectiveness (Phase 2)UnknownNCT05461690
What this trial is testing

Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency

Who this might be right for
Homologous Recombination DeficiencyTriple Negative Breast Cancer
Zhejiang Cancer Hospital 50
Post-approval studies (Phase 4)Study completedNCT00904410
What this trial is testing

Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET

Who this might be right for
Breast Cancer
Centre Oscar Lambret 63
Not applicableStudy completedNCT00340210
What this trial is testing

Extended Follow-up of Columbia, MO Serum Bank Participants

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer
National Cancer Institute (NCI) 6,720
Testing effectiveness (Phase 2)UnknownNCT02592213
What this trial is testing

Treatment of Breast Cancer Related Lymphedema With Cell-assisted Lipotransfer

Who this might be right for
Lymphedema
Odense University Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85
Testing effectiveness (Phase 2)Ended earlyNCT03241810
What this trial is testing

Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Elevation Oncology 22
Not applicableUnknownNCT05826197
What this trial is testing

Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics

Who this might be right for
Breast Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07766018
What this trial is testing

Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Stemline Therapeutics, Inc. 70
Not applicableUnknownNCT04903990
What this trial is testing

Circulating Fetal Cells and Breast Cancer

Who this might be right for
Breast Cancer
Assistance Publique - Hôpitaux de Paris 80
Not applicableUnknownNCT05094310
What this trial is testing

Genetic Predictors of Response to Acupuncture for Cancer-related Fatigue Among Breast Cancer Patients After Chemotherapy

Who this might be right for
Breast Cancer
Affiliated Hospital of Qinghai University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07394218
What this trial is testing

CtDNA-guided Treatment Decision-making

Who this might be right for
Metastatic Breast Cancer ( HER2 Negative)ctDNA
Fudan University 122
Next Page